We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Biochemical and Genetic Markers in Liver Diseases

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified October 2012 by Karolin Hoeh, University Hospital Heidelberg.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01706614
First Posted: October 15, 2012
Last Update Posted: October 15, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Karolin Hoeh, University Hospital Heidelberg
  Purpose
Investigation of biochemical and genetic markers in liver disease that might have an influence on the course of the disease

Condition
Biochemical and Genetic Markers in Liver Diseases

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Biochemical and Genetic Markers in Liver Diseases

Resource links provided by NLM:


Further study details as provided by Karolin Hoeh, University Hospital Heidelberg:

Estimated Enrollment: 500
Study Start Date: April 2012
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients with liver disease seen at department of Gastroenterology, University Hospital Heidelberg
Criteria

Inclusion Criteria:

  • suffering from liver disease
  • age of 18 years or older
  • agreement to participate in study

Exclusion Criteria:

  • younger than 18 years
  • no consent to participate
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01706614


Contacts
Contact: Karolin J Hoeh +49-6221-56-8702 karolin.hoeh@med.uni-heidelberg.de

Locations
Germany
University Hospital Heidelberg Recruiting
Heidelberg, Germany, 69120
Contact: Karolin J Hoeh    004962218702    karolin.hoeh@med.uni-heidelberg.de   
Principal Investigator: Karolin J Hoeh         
Sponsors and Collaborators
University Hospital Heidelberg
Investigators
Principal Investigator: Karolin J Hoeh University Hospital Heidelberg
  More Information

Responsible Party: Karolin Hoeh, Study Investigator, University Hospital Heidelberg
ClinicalTrials.gov Identifier: NCT01706614     History of Changes
Other Study ID Numbers: S-565/2011
First Submitted: October 10, 2012
First Posted: October 15, 2012
Last Update Posted: October 15, 2012
Last Verified: October 2012

Additional relevant MeSH terms:
Liver Diseases
Digestive System Diseases